Detalhe da pesquisa
1.
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
Oncologist
; 29(4): e514-e525, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297981
2.
High shear stress enhances endothelial permeability in the presence of the risk haplotype at 9p21.3.
APL Bioeng
; 5(3): 036102, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34327295